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ABSTRACT
BACKGROUND: The aim of our study is to minimize the morbidity related to nerve injury by determining the protective effects of 
gabapentin in experimental sciatic nerve injury and end-to-end anastomosis model in rats and to guide clinical studies on this subject.
METHODS: In our study, 40 adult male Sprague–Dawley rats were randomly divided into the following five groups: I: Only surgical 
intervention was applied; II: The sciatic nerve was cut properly and was repaired by end-to-end anastomosis. No additional procedure 
was performed; III: A single dose of gabapentin at 30 mg/kg was given after anastomosis; IV: 30 mg/kg gabapentin was given for 3 days 
after anastomosis; and V: 30 mg/kg gabapentin was given for 7 days after anastomosis. The experiment was terminated with high-dose 
thiopental (50 mg/kg) 60 days after the surgical intervention. The right sciatic nerve was taken from all animals. The obtained sections 
were examined immunohistopathologically.
RESULTS: Immunohistochemical properties and Schwann cell proliferation were found to be statistically significantly lower in the 
control group than in the other groups. Schwann cell proliferation was higher in Group 3 than in Group 5. Immunohistochemical 
changes were significantly lower in Group 4 than in Group 3. Axonal degeneration was also higher in Group 4 than in Group 3.
CONCLUSION: Gabapentin promotes neurological recovery histopathologically in peripheral nerve injury due to its neuropro-
tective properties. Our study results show that gabapentin can be used as an adjunctive therapy to primary surgical treatment after 
peripheral nerve injury.
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son. Nowadays, it is known that peripheral nerve injury oc-
curs in 2.8% of trauma patients.[3]
The aim of surgical treatment in peripheral nerve injuries is 
to ensure that the axons remain proximal to a transection so 
that they can reach their original distal ends during regenera-
tion and innervate the end organs.[4]
Currently accepted treatments in peripheral nerve injuries 
are as follows: 1) early end-to-end nerve repair for nerve 
transection injury and 2) graft repair when there are large 
gaps or tensions between damaged nerve endings.[5] In pe-
  EXPERIMENTAL STUDY
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INTRODUCTION
The statement “Once nerves are cut, they cannot be re-
paired” was accepted by many surgeons until the 20th century.
[1] First, in the 9th and 10th centuries, Arab surgeons began to 
suture peripheral nerve cuts.[2] When we look at the nerve 
graft techniques, we see that the first description was given 
by Gabriele Ferrara in the 17th century and that the stitches 
had been thrown with a tendon that was laid with red wine.[1]
Peripheral nerve injuries can occur due to mechanical, chem-
ical, and thermal reasons. Trauma is the most common rea-
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ripheral nerve repair, tension on the neural tissues is an unde-
sired situation. Studies on this subject show that an average 
of more than 10% tension applied to nerve endings to close 
the defect causes up to a 50% reduction in blood flow.[6] The 
failure of peripheral nerve repair leads to motor and sensory 
deficits and painful neuropathies in the target muscle. The 
gold standard treatment for peripheral nerve injury is pri-
mary end-to-end repair of two transected peripheral nerve 
endings; if this cannot be performed, nerve endings are con-
nected to each other using autologous sensory nerve graft.[7]
Peripheral nerve injuries were classified into three ma-
jor groups according to clinical condition and microscopic 
changes after nerve injury by Seddon in 1943: neurapraxia, ax-
onotmesis, and neurotmesis. Then, Sunderland expanded this 
classification from three to five degrees of peripheral nerve 
injury according to the severity of nerve injury (Table 1).[8–10]
These simple classifications are still currently used, especially 
for the follow-up and treatment of acute nerve injuries.[11]
Gabapentin, which has entered into clinical use as an adju-
vant anticonvulsant drug in the treatment of partial seizures 
in 1993, is widely used for neuropathic pain, migraine, and 
spasticity today.[12–14] The antinociceptive, anticonvulsant, 
anxiolytic, and neuroprotective effects of gabapentin have 
been shown in various animal models.[15]
It has been suggested that the neuroprotective effects of 
gabapentin may be related to changes in glutamate synthesis 
and metabolism.[13,16]
There are many studies investigating its neuroprotective 
effects in cerebral ischemia, cerebral trauma, spinal cord 
trauma, and peripheral nerve injury.
In the literature, to the best of our knowledge, there is no 
any study on the efficacy of gabapentin in peripheral nerve 
anastomosis.
The aim of this study was to examine the effects of gabapentin 
on nerve healing after an experimental rat sciatic nerve tran-
section was surgically repaired.
MATERIALS AND METHODS
The experimental protocol of our study was examined and 
approved by the Ethical Committee of Baskent University 
Medical and Health Sciences (Decision Date: 18/09/2015; 
Decision No: DA15/40). Our study was supported by the 
Baskent University Research Fund.
The animals used in the study were obtained from the 
Baskent University Experimental Animal Breeding Labora-
tory. All the experimental steps of the study were performed 
in the Baskent University Experimental Animal Research Lab-
oratory. Immunohistochemical examinations were completed 
in the Department of Pathology at Baskent University.
Animals
Forty male Sprague–Dawley rats (250–300 g; 12 weeks of 
age) were used in our study. The rats were kept at room 
temperature in a 12-hour light/12-hour dark cycle in the lab-
oratory environment for 60 days. All rats had free access to 
food and water. On the 60th day of the study, the animals 
were sacrificed to obtain samples for immunohistochemical 
examinations.
Groups and Surgical Procedures
In our study, rats were randomly assigned into five groups. All 
rats were administered xylazine 10 mg/kg (Rompun, Bayer) 
and ketamine 60 mg/kg (Ketalar, Pfizer) for anesthesia in-
traperitoneally before surgery.
All surgical procedures were performed by a single surgeon. 
Surgical procedures were applied to the right sciatic nerve of 
the rats.
Subsequently, subjects were fixed at the prone position, four 
extremities and their teeth on the wooden operation table 
with the band.
Group I (Control) (n=8): After the administration of anes-
thesia, the right hind limbs were prepared for surgery using a 
sterile technique. Skin incision was followed by dissection of 
the gluteal muscles to expose the sciatic nerve, including the 
tibial, peroneal, and sural branches, under a surgical micro-
Ulus Travma Acil Cerrahi Derg, September 2018, Vol. 24, No. 5482
Table 1. Seddon and Sunderland classification of peripheral nerve injury
Seddon’s classification Sunderland’s classification Injured tissues
Neurapraxia Grade I Myelin
Axonotmesis GradeII Myelin, axon
Neurotmesis Grade III Myelin, axon, endoneurium
 Grade IV Myelin, axon, endoneurium, perineurium
 Grade V Myelin, axon, endoneurium, perineurium epineurium
Source 8–10.
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scope (Opmi 9-FC, Carl Zeiss AG, Germany). This group’s 
sciatic nerves were only dissected under general anesthesia. 
No incision or anastomosis of the sciatic nerve was con-
ducted.
Group II (n=8): In addition to the surgical procedures de-
scribed in Group I, end to end (ETE) anastomosis of the 
proximal and distal stumps was performed after sectioning 
the sciatic nerve. Anastomoses were performed using 10–0 
nylon sutures. No additional treatment was applied to this 
group of animals (Fig. 1).
Group III (n=8): In addition to the surgical procedures de-
scribed in Group II, 30 mg/kg gabapentin was administered 
intraperitoneally to the animals in a single dose (4 h post-
treatment).
Group IV (n=8): In addition to the surgical procedures 
described in Group II, the animals were applied 30 mg/kg 
gabapentin intraperitoneally for 3 days.
Group V (n=8): In addition to the surgical procedures 
described in Group II, the animals were applied 30 mg/kg 
gabapentin intraperitoneally for 7 days.
Immunohistochemical Evaluation
Sciatic nerves dissected from the rats were fixed in 10% 
buffered formaldehyde. After a routine tissue process, the 
samples were embedded in paraffin blocks, and 5-mm-thick 
sections were cut axially using a microtome (RM 2245, Le-
ica) for hematoxylin and eosin (H&E) staining. Slides were 
evaluated under a light microscope (DMI 4000 B Leica) by 
a pathologist who was blinded to the groups. The presence 
of the Schwainan cells, inflammation, and axonal degenera-
tion were evaluated and scored semiquantitatively (0, absent; 
1, mild; 2, moderate; 3, severe/marked). Four micron-thick 
sections taken from the paraffin blocks were immunohisto-
chemically stained with anti-CACNA2D1 antibody (Abcam 
cat:2864) as the primary antibody and with rabbit Antimouse 
IgG (Abcam) as the secondary antibody. The results were 
scored semiquantitatively (0, absent, 1, mild; 2, moderate; 3, 
strong).
Statistical Methods
The IBM SPSS 24.0 statistic software (IBM Corporation 
Armonk, NY, USA) was used to analyze the variables. The 
Kruskal–Wallis H test was used to compare more than two 
groups with each other according to quantitative data. The 
Dunn’s test was used for post-hoc analysis.
Quantitative variables were shown as median and range 
(maximum–minimum) in tables. These variables were exam-
ined at a 95% confidence level. A p-value of less than 0.05 was 
considered statistically significant.
RESULTS
When Schwann cell proliferation was evaluated according 
to the groups, there was a statistically significant difference 
(p<0.001). The median value of Schwann cell proliferation 
was lower in Group 1 (0 [0/0]) than in Groups 2, 3, 4, and 
5 (respectively, 1.08 [0/2]; 1.56 [1/2]; 1.07[0/2]; and 0.86 
[0/2]). This difference was statistically significant (all p-values 
<0.001). Moreover, the median value of Schwann cell pro-
liferation was higher in Group 3 (1.56 [1/2]) than in Group 
5 (0.86[0/2]). This difference was statistically significant 
(p=0.008). There were no significant differences between 
other groups (p>0.05).
When axonal degeneration was evaluated according to 
the groups, there was a statistically significant difference 
(p<0.001). The median value of axonal degeneration was 
higher in Group 4 (1.75 [1/2]) than in Group 3 (1.07 [0/2]). 
The median value of axonal degeneration was lower in Group 
5 (1.07 [0/2]) than in Group 4 (1.75 [1/2]). These differences 
were statistically significant (p<0.001).
The median value of inflammation was found to be the same 
in Group 1 (control group) (0.13 [0/1]) and in Groups 4 and 5 
(respectively, 0.13 [0/1] and 0.13 [0/1]). There was no statis-
tically significant difference between these groups (p>0.05).
When we evaluated immunohistochemical changes, there 
was a statistically significant difference between Group 1 
and Groups 2, 3, 4, and 5 (p<0.001). Immunohistochemical 
changes were significantly lower in the control group than 
in other groups. Moreover, the median value of immunohis-
tochemical changes was lower in Group 4 (1 [0/2]) than in 
Group 3 (1.64 [1/3]). This difference was statistically signif-
icant (p<0.001). Immunohistochemical changes were signifi-
cantly lower in Group 4 than in Group 3 (Table 2).
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Figure 1. Image of sciatic nerve that was end to end anastomosed.
DISCUSSION
Peripheral nerves can be damaged due to many reasons. Th-
ese include mechanical factors such as pressure, tension, and 
violence, as well as thermal, ischemic, radial, electrical, and 
chemical factors.[8]
Peripheral nerve injury, which is currently a major health 
problem, causes a high rate of disablement and an enormous 
economic burden.[17]
It constitutes an important group of diseases, especially in in-
dustrialized countries.[18] More than 350,000 people per year 
in the United States are exposed to upper extremity injury.[18]
Peripheral nerve injury is seen in 2.8%–5% of trauma cases.[18,19]
Partial or total motor and sensory loss, loss of autonomic 
function, and neuropathic pain may develop due to peripheral 
nerve injury.[20] This can lead to long-term disability and re-
duce the quality of life and cause material damage.[21]
Today, the gold standard treatment for peripheral nerve injury 
is ETE anastomosis. To provide a tension free primary nerve 
repair, different techniques can be used, such as re-routing of 
nerve, mobilization of nerve ends, and bone shortening. This 
is followed by nerve graft and nerve bridge.[20,22]
Therefore, there is a need for developing clinically relevant 
models to understand the peripheral nerve injury pathophys-
iology and to evaluate potential treatments.[21]
When we examined the literature, various techniques have 
been proposed to improve the functional outcomes of sur-
gical repair of nerve transection. Nerve and vascular grafts, 
denatured muscle fibers, and fascial layers are examples of 
natural tubulization.[23–26] Polyglycolic acid, polyglycan, poly-
ethylene, and silicone were used for synthetic tubulization.
[23,27,28] Yapici et al.[22] reported that vascularized nerve conduit 
graft showed better regeneration compared to non-vascular-
ized nerve conduit graft but that it cannot be an alternative 
to autogenous nerve graft.
Dos Reis et al.[29] reported that laser therapy had positive 
effects on post-anastomotic regeneration of damaged nerves.
Ozbek et al.[30] showed that the use of anastomosis and 
genistein contributed to nerve healing in experimental sciatic 
nerve injury.
We also aimed to examine the effects of gabapentin on nerve 
healing after experimental rat sciatic nerve transection was 
surgically repaired.
The mechanism of action of gabapentin, which is a lipophilic 
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Table 2. Statistical comparison of Schwann cell proliferation, axonal degeneration, inflammation, and immunohistochemical changes 
according to the groups
   Schwann C.Proliferation  Axonal Degeneration  Inflammation  Immunohistochemistry
    Med. (Min./Max.)  Med. (Min./Max.)  Med. (Min./Max.)  Med. (Min./Max.)
Group 1 =I 0 (0/0) 1 (1/1) 0.13 (0/1) 0.06 (0/1)
Group II =II 1.08 (0/2) 1.44 (1/2) 0.92 (0/2) 1.57 (0/3)
Group III =III 1.56 (1/2) 1.07 (0/2) 0.53 (0/2) 1.64 (1/3)
Group IV =IV 1.07 (0/2) 1.75 (1/2) 0.13 (0/1) 1 (0/2)
Group V =V 0.86 (0/2) 1.07 (0/2) 0.13 (0/1) 1.38 (0/3)
Total   0.89 (0/2) 1.27 (0/2) 0.34 (0/2)  1.13 (0/3)
P-value  <0.001 <0.001 <0.001  <0.001
Binary comparisons I→II <0.001 0.010 <0.001 <0.001
 I→III <0.001 0.641 0.025 <0.001
 I→IV <0.001 <0.001 1 0.001
 I→V <0.001 0.625 1 <0.001
 II→III 0.053 0.036 0.098 0.746
 II→IV 0.954 0.067 <0.001 0.056
 II→V 0.470 0.042 <0.001 0.566
 III→IV 0.060 <0.001 0.025 0.026
 III→V 0.008 0.976 0.025 0.369
 IV→V 0.435 <0.001 1 0.182
Kruskal–Wallis H Test (Monte Carlo); Post Hoc Test; Dunn’s Test; Med.: Medyan; Min.: Minumum; Max.: Maximum.
GABA analog (an inhibitory neurotransmitter), is still un-
clear. It is thought that it decreases glutamate-induced cell 
death in both the central and peripheral nervous system 
by reducing neuronal cytoplasmic glutamate concentrations 
in vivo through selective antagonism of an AMPA-type glu-
tamate receptor.[12,15,31] There are many studies showing 
the neuroprotective effects of gabapentin. Kale et al.[15] re-
ported that gabapentin had a neuroprotective effect in spinal 
cord ischemia-reperfusion injury in rabbits. Rekling et al.[32] 
showed that gabapentin had a neuroprotective effect on rat 
hippocampus.
In our study, Schwann cell proliferation, axonal degeneration, 
and inflammation were not observed in the control group 
(Fig. 2). The nerve tissue with prominent Schwann cell prolif-
eration was in Group 3, and the nerve tissue with prominent 
inflammation in addition to Schwann cell proliferation was in 
Group 2 (Fig. 2).
There was no statistically significant difference between 
Group 1 and Groups 4 and 5 in terms of inflammation. 
This result proved the strong anti-inflammatory activity of 
gabapentin. Although not statistically significant, even in the 
single-dose gabapentin group (Group 3), inflammation was 
less in Group 2. After 3 and 7 days, it was proven that in-
flammation was at the level of the control group. And these 
findings were meaningful with the literature.[14,16,30,33,34] 
In Group 4, significant axonal degeneration was observed 
(Fig. 2).
In our study, there was a statistically significant difference 
between the control group (Group 1) and other groups in 
terms of Schwann cell proliferation. Schwann cell prolifer-
ation was significantly lower in the control group. When 
the relationships between the other groups were evaluated, 
Schwann cell proliferation was lower in Group 5 than in 
Group 3. 
In an experimental setting, behavior is accepted as motor 
symptoms of physiopathological processes. Behavioral im-
provement after peripheral nerve injury is the most impor-
tant measure of healing for real patients.[18] Functional evalua-
tion is a standard metric for motor function assessment that 
reflects nerve function after peripheral nerve injury.[30] How-
ever, functional evaluation was not performed in our study 
because nerve regeneration and functional recovery were not 
completed on the 60th day. This can be investigated by a long-
term study; however, it is not possible to evaluate this with 
the results of this study.[3]
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Figure 2. (a) Control group; Schwann cell proliferation, axonal degeneration, and no inflammation (Group 1) (x10, H&E). 
(b) Neuronal tissue with prominent Schwann cell proliferation (Group 3) (x20, H&E). (c) Neural tissue showing significant 
axonal degeneration (Group 4) (x20, H&E). (d) Significant Schwann cell proliferation and inflammation (Group 2) (x20, H&E).
(a)
(c)
(b)
(d)
We must travel a considerable distance to achieve the ideal 
treatment of peripheral nerve injury. The processes of de-
generation and regeneration after nerve injury are not fully 
understood with current information. The clarification of 
these processes will constitute the basis for progress in the 
treatment of peripheral nerve injury.[3]
Conclusion 
The results of our study show that gabapentin can be used 
as an adjuvant therapy to surgical treatment after peripheral 
nerve injury. Gabapentin functionally and histopathologically 
promotes neurological recovery in peripheral nerve injury.
However, the importance of microsurgery experience in 
treatment should not be forgotten.
Conflict of interest: None declared.
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AMAÇ: Çalışmamızın amacı; sıçanlarda deneysel olarak oluşturulan siyatik sinir yaralanması ve uç-uca anastomoz yapılması modelinde gabapentinin 
koruyucu etkilerini belirleyerek sinir yaralanmasına bağlı morbiditeyi en aza indirmek ve bu konudaki klinik çalışmalara yön vermektir.
GEREÇ VE YÖNTEM: Çalışmamızda 40 adet yetişkin, erkek, Sprague-Dawley cinsi sıçanlar; rastgele I: Sadece cerrahiye maruz kalan, II: siyatik 
sinirleri düzgün bir şekilde kesilip tekrar uç-uca anastomoz yapılan ve ek herhangi bir işlem yapılmayan, III: anastomoz yapılıp tek doz 30 mg/kg 
gabapentin verilen, IV: anastomoz yapılıp üç gün 30 mg/kg gabapentin verilen, V: anastomoz yapılıp yedi gün 30 mg/kg gabapentin verilen olmak 
üzere beş gruba ayrıldı. Cerrahi işlemden 60 gün sonra yüksek doz tiyopental (50 mg/kg) ile deney sonlandırıldı. Tüm hayvanların sağ siyatik sinirleri 
alındı ve elde edilen kesitler immünohistopatolojik olarak incelendi.
BULGULAR: İmmünohistokimyasal özellikler ve Schwann hücre proliferasyonu kontrol grubunda, diğer gruplara kıyasla istatistiksel olarak anlamlı 
daha az oranda saptandı. İkili gruplar arasında ise Grup 3’de 5’e oranla daha fazla hücre proliferasyonu görüldü. Grup 4’deki immünohistokimyasal 
değişiklikler Grup 3’e göre anlamlı oranda az saptandı. Ayrıca axonal dejenerasyon da Grup 4’de Grup 3’e oranla daha fazla bulundu.
TARTIŞMA: Gabapentin, histopatolojik olarak periferik sinir yaralanmasında nöroprotektif  özelliği ile nörolojik düzelmeyi teşvik eder. Çalışmamızın 
sonuçlarında, gabapentinin, periferik sinir hasarı sonrasında primer cerrahi tedaviye ek tamamlayıcı bir tedavi olarak kullanılabilirliğini göstermek-
tedir.
Anahtar sözcükler: Anastomoz; gabapentin; periferik sinir; siyatik sinir; travma.
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